Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis

Michela Giustozzi, Maria Cristina Vedovati, Paolo Verdecchia, Lucia Pierpaoli, Melina Verso, Serenella Conti, F Cianella, Emanuela Marchesini, Esmeralda Filippucci, Giancarlo Agnelli, Cecilia Becattini

Article2023

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study

Shin-Huei Liu, Yi‐Hsin Chan, Jo‐Nan Liao, Tzeng‐Ji Chen, Professor Gregory Lip, Shih-Ann Chen

Article2019

Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease

Hsin‐Fu Lee, Lai‐Chu See, Pei‐Ru Li, Jia‐Rou Liu, Tze‐Fan Chao, Shang‐Hung Chang, Lung‐Sheng Wu, Yung‐Hsin Yeh, Chi‐Tai Kuo, Yi‐Hsin Chan, Professor Gregory Lip

Article2015

Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort

Michela Giustozzi, Maria Cristina Vedovati, F Cianella, Paolo Verdecchia, Melina Verso, Serenella Conti, Esmeralda Filippucci, Emanuela Marchesini, Giancarlo Agnelli, Cecilia Becattini

Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis

Discussion(0)

Related publications

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage

Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study

Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease

Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort